These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14634866)

  • 1. Efficacy of losartan in the treatment of erythrocytosis in a young adult with CRF.
    Stoll ML; Gauthier BG; Vergara M; Ramek J; Frank R; Trachtman H
    Pediatr Nephrol; 2004 Jan; 19(1):120-1. PubMed ID: 14634866
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of losartan on the treatment of posttransplant erythrocytosis.
    Navarro JF; García J; Macía M; Mora C; Chahin J; Gallego E; Méndez ML; del Castillo N
    Clin Nephrol; 1998 Jun; 49(6):370-2. PubMed ID: 9696433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of losartan on posttransplant erythrocytosis.
    Colak T; Emiroglu R; Karakayali H; Haberal M
    Transplant Proc; 2001; 33(1-2):2014-5. PubMed ID: 11267606
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].
    Morale W; Puliatti C; Veroux P; Veroux M; Valvo C; Cappello D; Puliatti D; Francesco L
    Minerva Urol Nefrol; 2002 Jun; 54(2):145-8. PubMed ID: 12070465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan versus ramipril in the treatment of postrenal transplant erythrocytosis.
    Hortal L; Fernández A; Vega N; Rodríguez JC; Losada A; Lorenzo M; Plaza C; Palop L
    Transplant Proc; 1998 Aug; 30(5):2127-8. PubMed ID: 9723415
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors for secondary erythrocytosis.
    Fakhouri F; Grünfeld JP; Hermine O; Delarue R
    Ann Intern Med; 2004 Mar; 140(6):492-3. PubMed ID: 15023727
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of postrenal transplant erythrocytosis. Long-term efficacy and safety of angiotensin-converting enzyme inhibitors.
    MacGregor MS; Rowe PA; Watson MA; Rodger RS; Junor BJ; Briggs JD
    Nephron; 1996; 74(3):517-21. PubMed ID: 8938674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients.
    Kupin W; Venkat KK; Goggins M; Abouljoud M; Escobar F; Mozes M
    Transplant Proc; 1997; 29(1-2):207-8. PubMed ID: 9122965
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors].
    Morale W; Puliatti C; Veroux P; Veroux M; Valvo C; Cappello D; Puliatti D; Francesco L
    Minerva Urol Nefrol; 2002 Sep; 54(3):189-92. PubMed ID: 12384621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythrocytosis post kidney transplantation and its pharmacological treatment: angiotensin converting enzyme inhibitors or angiotensin receptor blockers in a case].
    Duclos J
    Rev Med Chil; 2000 Feb; 128(2):211-2. PubMed ID: 10962891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights and treatment in posttransplant polycythemia (erythrocytosis) of renal recipients.
    Sauron C; Berthoux P; Berthoux F; Alamartine E; Diab N; Broyet C; Hacini J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1032-3. PubMed ID: 8382847
    [No Abstract]   [Full Text] [Related]  

  • 12. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ; Stapff M; Lin Y
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic perspectives: association of ACE inhibitors and angiotensin receptor blockers].
    Costantino S; Millozzi F; Scarlata S
    Clin Ter; 2001; 152(2):77-8. PubMed ID: 11441526
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and their combination on microalbuminuria in normotensive patients with type 2 diabetes.
    Atmaca A; Gedik O
    Adv Ther; 2006; 23(4):615-22. PubMed ID: 17050503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No acute additive effect of losartan in a patient already on an ACE inhibitor for heart failure.
    Missouris CG; Patel SJ; Morton JJ; MacGregor GA
    J Hum Hypertens; 1999 Nov; 13(11):797-8. PubMed ID: 10578227
    [No Abstract]   [Full Text] [Related]  

  • 16. Post-transplant erythrocytosis refractory to ACE inhibitors and angiotensin receptor blockers.
    Vishnu P; Moreno Vanegas Y; Wadei HM; Rivera CE
    BMJ Case Rep; 2018 Jun; 2018():. PubMed ID: 29954763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Losartan, an angiotensin II type 1 receptor antagonist, lowers hematocrit in posttransplant erythrocytosis.
    Julian BA; Brantley RR; Barker CV; Stopka T; Gaston RS; Curtis JJ; Lee JY; Prchal JT
    J Am Soc Nephrol; 1998 Jun; 9(6):1104-8. PubMed ID: 9621296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis.
    Glicklich D; Burris L; Urban A; Tellis V; Greenstein S; Schechner R; Devarajan P; Croizat H
    J Am Soc Nephrol; 2001 Sep; 12(9):1958-1964. PubMed ID: 11518790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
    Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of losartan, lisinopril and their combination on hemodynamics and morphofunctional parameters of the heart in patients with chronic cardiac failure].
    Tofan EF; Butorov IV; Gonchar VI; Nekula GI
    Klin Med (Mosk); 2011; 89(1):40-4. PubMed ID: 21516765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.